*Result*: Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): an externally controlled study
*Title*:
Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): an externally controlled study = Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3K[delta]) syndrome (APDS): an externally controlled study
*Author/editor-in-chief*:
Whalen, John (Verfasser); Chandra, Anita (Verfasser); Kracker, Sven (Verfasser) ; Ehl, Stephan (Verfasser) ; Seidel, Markus G. (Verfasser); Gulas, Ioana (Verfasser); Dron, Louis (Verfasser); Velummailum, Russanthy (Verfasser); Nagamuthu, Chenthila (Verfasser); Liu, Sichen (Verfasser); Tutein Nolthenius, Joanne (Verfasser); Maccari, Maria Elena (Verfasser) ; Grimbacher, Bodo (Verfasser) ; Kindle, Gerhard (Verfasser) ; Speckmann, Carsten (Verfasser)
*Publication*:
Freiburg : Universität, 2025
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
Clinical & experimental immunology. - 219, 1 (2025) , uxae107, ISSN: 1365-2249
*DOI*:
10.1093/cei/uxae107